Effect of Telmisartan and Ramipril on Atrial Fibrillation Recurrence and Severity in Hypertensive Patients With Metabolic Syndrome and Recurrent Symptomatic Paroxysmal and Persistent Atrial Fibrillation-Reference-Cited by-同舟云学术

Effect of Telmisartan and Ramipril on Atrial Fibrillation Recurrence and Severity in Hypertensive Patients With Metabolic Syndrome and Recurrent Symptomatic Paroxysmal and Persistent Atrial Fibrillation

Published:2011-02-18 Issue:1 Volume:17 Page:34-43
ISSN:1074-2484
Container-title:Journal of Cardiovascular Pharmacology and Therapeutics
language:en
Short-container-title:J Cardiovasc Pharmacol Ther

Author:

Fogari Roberto¹,Mugellini Amedeo¹,Zoppi Annalisa¹,Preti Paola¹,Destro Maurizio¹,Lazzari Pierangelo¹,Derosa Giuseppe¹

Affiliation:

1. Department of Internal Medicine and Therapeutics, Centro per l’ipertensione e la fisiopatologia cardiovascolare, University of Pavia, Pavia, Italy

Publisher

SAGE Publications

Subject

Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology

Link

http://journals.sagepub.com/doi/pdf/10.1177/1074248410395018

Reference62 articles.

1. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: population-based estimates 11Reprints are not available.

2. A population-based study of mortality among patients with atrial fibrillation or flutter

3. High Prevalence of Paroxysmal Atrial Fibrillation and/or Atrial Flutter in Metabolic Syndrome

4. Metabolic Syndrome and Risk of Development of Atrial Fibrillation

5. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiology and clinical relevance of atrial myopathy;Basic Research in Cardiology;2024-03-12

2. Metabolic Syndrome and Atrial Fibrillation: Different Entities or Combined Disorders;Journal of Personalized Medicine;2023-08-28

3. Elevated chymase-dependent angiotensin II-forming activity in circulating mononuclear leukocytes was observed in the patient of atrial fibrillation;Heart and Vessels;2020-03-23

4. Telmisartan and moksonidin’s opportunities in treatment of arterial hypertension;Kardiologiya i serdechno-sosudistaya khirurgiya;2020

5. Angiotensin II and angiotensin 1–7: which is their role in atrial fibrillation?;Heart Failure Reviews;2019-08-02